The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks.
As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory.
The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:
- Stage of Automation
- Pre-Analytical
- Analytical
- Post-Analytical
- Total Lab Automation
- Type of Instrument
- Automated Liquid Handling Systems
- Automated Microplate Readers
- Automated Sampling Systems
- Analyzers
- Automated Storage and Retrieval Systems (ASRS)
- Other Instruments
- End-User
- Pharmaceutical and Biotechnology Companies
- Research and Diagnostic Laboratories
- Other End-Users
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Middle East and North Africa
- Latin America
The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
- Abbott
- Anton Paar
- BD
- Beckman Coulter
- ERWEKA
- Leuze
- Ortho Clinical Diagnostics
- Pall Corporation
- PerkinElmer
- Roche Diagnostics
- Siemens Healthineers
- SYSTAG
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Partnerships and Collaborations
8. Patent Analysis
9. Market Forecast and Opportunity Analysis
10. Case Study: Lab Automation Software
11. Executive Insights
12. Appendix 1: Tabulated Data
13. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
Learn from experts: do you know about these emerging industry trends?
Top 5 Companies Developing Bispecific Antibodies
Top 10 Cell and Gene Therapy Companies
Learn from our recently published whitepaper: –
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Contact:
Ben Johnson
+1 (415) 800 3415